Rankings
▼
Calendar
TMDX Q4 2020 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena
TMDX
TransMedics Group, Inc.
$5B
Q4 2020 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$8M
+25.9% YoY
Gross Profit
$5M
63.3% margin
Operating Income
-$6M
-77.3% margin
Net Income
-$6M
-82.7% margin
EPS (Diluted)
$-0.23
QoQ Revenue Growth
+7.6%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$698,000
Balance Sheet
Total Assets
$152M
Total Liabilities
$48M
Stockholders' Equity
$104M
Cash & Equivalents
$25M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$8M
$6M
+25.9%
Gross Profit
$5M
$4M
+29.1%
Operating Income
-$6M
-$9M
+32.2%
Net Income
-$6M
-$9M
+31.2%
Revenue Segments
Ocs Lung Product
$3M
41%
Ocs Heart Product
$2M
32%
Ocs Liver Product
$2M
28%
Geographic Segments
UNITED STATES
$6M
52%
Non Us And Uk
$5M
48%
← FY 2020
All Quarters
Q1 2021 →